News Breaks |
|
|
| March 13, 2012 |
| 09:32 EDT |  | IDIX, GILD | Gilead likely to sign licensing deal with Idenix, says Leerink
Leerink hosted a conference call with a MEDACorp specialist yesterday to go over Gillead's (GILD) and Idenix's (IDIX) USTPO patent dispute. Based on the call, Leerink believes Gilead will end up in a licensing deal with Idenix which will result in royalties on U.S. sales. |
|
|
News For IDIX;GILD From The Last 14 Days Check below for free stories on IDIX;GILD the last two weeks. |
|
|
| May 21, 2013 |
| 16:51 EDT |  | GILD | Gilead's sofosbuvir gets EMA validation, now under assessment
 Subscribe for More Information |
|
| 07:34 EDT |  | IDIX | UBS to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 07:34 EDT | | GILD | UBS to host a conference
Subscribe for More Information |
|
| May 16, 2013 |
| 11:50 EDT | | GILD | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information |
|
| May 15, 2013 |
| 18:32 EDT | | GILD | Gilead announces response data from Phase 2 study of Idelalisib
Subscribe for More Information |
|
| May 13, 2013 |
| 09:39 EDT |  | GILD | Active equity option families trading
Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR |
|
|
|
|
|
